Preclinical data suggest suppression of cancer proliferation by propofol, and retrospective studies suggest improved survival after cancer surgery with propofol-based anaesthesia.

Association between propofol dose and 1-year mortality in patients with and without a diagnosis of solid cancer

Landoni, Giovanni
Penultimo
;
2020-01-01

Abstract

Preclinical data suggest suppression of cancer proliferation by propofol, and retrospective studies suggest improved survival after cancer surgery with propofol-based anaesthesia.
2020
Inglese
124
124
3
271
280
10
Pubblicato
cancer; electronic medical record; general anaesthesia; mortality; propofol; retrospective analysis; risk reduction behaviour
OSR
none
12
info:eu-repo/semantics/article
262
Schaefer, Maximilian S; Raub, Dana; Xu, Xinling; Shaydenfish, Denys; Teja, Bijan; Chhangani, Khushi; Grabitz, Stephanie D; O'Gara, Brian; Kienbaum, Pe...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/97407
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 20
social impact